Mirmiran Parvin, Bahadoran Zahra, Ghasemi Asghar, Hosseinpanah Farhad
Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Endocrine Physiology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Crit Rev Oncog. 2019;24(3):223-233. doi: 10.1615/CritRevOncog.2019031153.
Epidemiological studies have demonstrated an association between type 2 diabetes (T2DM) and the development of different types of cancer including those of the liver, pancreas, endometrium, colon and rectum, breast, and bladder. The association between T2DM and cancers may partly be due to shared common risk factors of these pathologic conditions and/or anti-diabetic treatments. Hyperglycemia and hyperinsulinemia, two important features of T2DM, are more clinically relevant factors in cancer development. Other factors, including the increased levels of insulin-like growth factor, steroid and peptide hormones, oxidative stress, and inflammatory markers, are also involved in the connection between T2DM and cancer. This review provides a brief overview of the epidemiological evidence supporting the association of T2DM and cancer and discusses the most important potential causes.
流行病学研究表明,2型糖尿病(T2DM)与包括肝癌、胰腺癌、子宫内膜癌、结肠癌、直肠癌、乳腺癌和膀胱癌在内的不同类型癌症的发生之间存在关联。T2DM与癌症之间的关联可能部分归因于这些病理状况的共同风险因素和/或抗糖尿病治疗。高血糖和高胰岛素血症是T2DM的两个重要特征,在癌症发展中是更具临床相关性的因素。其他因素,包括胰岛素样生长因子、类固醇和肽类激素水平升高、氧化应激和炎症标志物,也与T2DM和癌症之间的联系有关。本综述简要概述了支持T2DM与癌症关联的流行病学证据,并讨论了最重要的潜在原因。